Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1174.8000 -25.70 (-2.14%)

NSE Apr 25, 2025 15:31 PM

52W Low on Apr 07, 2025

Volume: 1.3M

Dr. Reddy's Laboratories Ltd.

06 Nov 2024

1174.80

-2.14%

Dr Reddy's Labs (HOLD): Healthy Q2; margins post gRevlimid LOE to remain wary

Hold: Dr. Reddy's Laboratories Ltd.

BOB Capital Markets Ltd.

Revenue/EBITDA earnings above our and street estimates. APAT ~46% above estimates. Estimates adjusted for JV and impairment cost

Dr. Reddy's Laboratories Ltd. is trading above its 50 day SMA of 1158.1